Coya Therapeutics Inc (COYA)

Name: Coya Therapeutics Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-03-31

Latest Quarter

2025-03-31

Revenue

$258K

Net Income

-$7.3M

Operating Margin

-2,976.9%

Free Cash Flow

-$10.7M

Debt / Assets

13.9%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Coya Therapeutics Inc (COYA).
Income Statement (Quarterly)	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Revenue	257,884	1,952	0	3,425,000
Cost of Revenue	0	6,840	0	0
Gross Profit	257,884	-4,888	0	3,425,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	2,713,890	2,138,000	2,220,000	2,088,000
Operating Expenses	7,934,806	4,082,000	4,450,000	6,655,000
Operating Income	-7,676,922	-4,080,000	-4,450,000	-3,236,000
Interest Expense	0	0	0	0
Income Before Tax	-7,306,757	-3,636,000	-4,021,000	-2,892,000
Income Tax Expense	0	0	0	0
Net Income	-7,306,757	-2,916,000	-4,021,000	-2,892,000
Per Share
EPS	-0.44	-0.18	-0.26	-0.19
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Coya Therapeutics Inc (COYA).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	7,945,753	3,554,061	6,002,000	0	0
Cost of Revenue	27,361	11,865,654	27,361	27,361	0
Gross Profit	7,918,392	-8,311,593	6,002,000	-27,361	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	11,449,466	8,885,757	7,833,000	4,847,080	2,312,042
Operating Expenses	28,184,015	8,938,118	13,906,000	9,811,939	4,870,310
Operating Income	-20,265,623	-17,249,711	-7,903,000	-9,811,939	-4,870,310
Interest Expense	0	0	0	2,432,837	0
Income Before Tax	-21,223,018	-15,601,074	-7,264,000	-12,244,776	-4,891,792
Income Tax Expense	3,089	-720,287	723,852	2,432,837	0
Net Income	-21,226,107	-14,880,787	-7,988,000	-14,677,613	-4,891,792
Per Share
EPS	-1.27	-0.98	-0.79	-1.48	-1.26
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Coya Therapeutics Inc (COYA).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	46,822,786	38,339,762	32,626,768	5,933,702
Short Term Investments	0	38,301,422,238	0	0
Net Receivables	0	730,581	7,500,000	0
Inventory	0	0	0	0
Total Current Assets	49,939,018	44,308,428	41,196,325	7,184,966
Property Plant Equipment	11,227	38,588	65,949	93,310
Goodwill and Intangibles	0	0	0	0
Total Assets	49,950,245	44,347,016	41,273,524	8,395,566
Liabilities
Account Payables	1,061,122	1,588,128	1,155,656	1,815,270
Short Term Debt	0	0	723,852	0
Total Current Liabilities	5,871,891	3,824,474	5,051,980	3,823,631
Long Term Debt	0	0	0	12,965,480
Total Liabilities	6,922,015	4,769,921	5,626,665	16,789,111
Shareholders Equity
Retained Earnings	-61,963,277	-40,737,170,000	-25,856,383	-17,868,547
Total Shareholders Equity	43,028,230	39,577,095	35,646,859	-8,393,545

Balance sheet annual history for Coya Therapeutics Inc (COYA).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	46,822,786	38,339,762	32,626,768	5,933,702	4,340,178
Short Term Investments	0	38,301,422,238	0	0	0
Net Receivables	0	730,581	7,500,000	0	0
Inventory	0	0	0	0	0
Total Current Assets	49,939,018	44,308,428	41,196,325	7,184,966	4,584,258
Property Plant Equipment	11,227	38,588	65,949	93,310	120,671
Goodwill and Intangibles	0	0	0	0	0
Total Assets	49,950,245	44,347,016	41,273,524	8,395,566	4,792,110
Liabilities
Account Payables	1,061,122	1,588,128	1,155,656	1,815,270	857,567
Short Term Debt	0	0	723,852	0	0
Total Current Liabilities	5,871,891	3,824,474	5,051,980	3,823,631	1,148,383
Long Term Debt	0	0	0	12,965,480	0
Total Liabilities	6,922,015	4,769,921	5,626,665	16,789,111	1,148,383
Shareholders Equity
Retained Earnings	-61,963,277	-40,737,170,000	-25,856,383	-17,868,547	-5,623,771
Total Shareholders Equity	43,028,230	39,577,095	35,646,859	-8,393,545	3,643,727

Cash flow quarterly history for Coya Therapeutics Inc (COYA).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-21,226,107	-14,880,787	-7,987,836	-12,244,776
Depreciation & Amortization	27,361	27,361	27,361	27,361
Stock Based Compensation	4,290,315	2,663,539	872,248	207,346
Change in Working Capital	3,879,528	1,876,065	-4,643,770	751,838
Operating Cash Flow	-10,739,301	-10,288,822	-11,188,811	-7,239,354
Investing Activities
Capital Expenditure	0	0	1	0
Investments	-1,164,602	0	1	0
Investing Cash Flow	-1,164,602	-25,000	-543,186	-525,000
Financing Activities
Debt Repayment	0	0	0	-9,471,600
Common Stock Issued/Repurchased	20,348,653	14,004,381	38,425,063	158
Dividends Paid	0	0	0	0
Financing Cash Flow	20,386,927	16,026,816	38,425,063	9,357,878
Summary
Free Cash Flow	-10,739,301	-10,288,822	-11,188,810	-7,239,354
Net Change in Cash	8,483,024	5,712,994	26,693,066	1,593,524

Cash flow annual history for Coya Therapeutics Inc (COYA).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-21,226,107	-14,880,787	-7,987,836	-12,244,776	-4,891,792
Depreciation & Amortization	27,361	27,361	27,361	27,361	16,133
Stock Based Compensation	4,290,315	2,663,539	872,248	207,346	233,222
Change in Working Capital	3,879,528	1,876,065	-4,643,770	751,838	739,169
Operating Cash Flow	-10,739,301	-10,288,822	-11,188,811	-7,239,354	-3,903,268
Investing Activities
Capital Expenditure	0	0	1	0	-136,804
Investments	-1,164,602	0	1	0	-136,804
Investing Cash Flow	-1,164,602	-25,000	-543,186	-525,000	-136,804
Financing Activities
Debt Repayment	0	0	0	-9,471,600	0
Common Stock Issued/Repurchased	20,348,653	14,004,381	38,425,063	158	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	20,386,927	16,026,816	38,425,063	9,357,878	-340,584
Summary
Free Cash Flow	-10,739,301	-10,288,822	-11,188,810	-7,239,354	-4,040,072
Net Change in Cash	8,483,024	5,712,994	26,693,066	1,593,524	-340,584